Patents

US 12734194 B2: Prophylactic and therapeutic use of mitochondria and combined mitochondrial agents

Granted
2026-09-15
Filed
2019-10-30 application 17607975
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure relates to compositions comprising isolated mitochondria or combined mitochondrial agents, and methods of treating or preventing disorders or damage associated with ischemia-reperfusion injury (IRI) using such compositions.

Source: PTBLXML, file of 2026-09-15 (ipgb20260915.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Children's Medical Center Corporation 717 patentsUS company or organizationBoston, MATHE CHILDREN'S MEDICAL CENTER CORPORATION State business registration FUZZY medium confidence: same name (legal endings aside) and statePTBLXML, file of 2026-09-15

Inventors

InventorPlacePatentsPerson pageSource
James D. McCullyMarblehead, MA10PTBLXML, file of 2026-09-15
Pedro J. del NidoLexington, MA28PTBLXML, file of 2026-09-15

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/12PTBLXML, file of 2026-09-15
A61BDiagnosis; surgery; identificationA61B6/504PTBLXML, file of 2026-09-15
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P9/10PTBLXML, file of 2026-09-15

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.